- Lobbying
- Lobbying by ELECTRO MEDICAL SYSTEMS CORPORATION
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Gerry Sikorski | 1983-93 Member, U.S. House of Representatives |
Kevin Doran | 1/04-1/05 Clrk, S. Cmte Hmlnd Sec./Govt Affairs 3/03-1/04 Staff Ast, S. Cmte Hmlnd Sec/Gvt Affrs 9/02-3/03 Staff Assistant, Senator Voinovich |
Lisa Barkovic | 1/01-4/05 Leg. Asst, Rep. Tom Foley |
Joel Roberson | 5/02-12/02 Cmte. Lias., H. Republican Conf. 1/03-8/04 Floor Debate Coord, H. Rep. Conf. 5/05-8/05 Law Clerk, H. Judiciary Committee |
Michael Gaba | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Food & Drug Administration (FDA)
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Food & Drug Administration (FDA),
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Food & Drug Administration (FDA),
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Registration
Issue(s) they said they’d lobby about: FDA policy..
Registration
Issue(s) they said they’d lobby about: FDA policy..
Q2 Report
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate